As previously demonstrated, activation of NF-κB has been linked to multiple pathophysiological conditions such as cancer, arthritis, asthma, inflammatory bowel disease, and other inflammatory conditions (Baldwin 2001b). Here, NFKB1 is linked to inflammatory bowel disease.